Garagiola Maria L, Tan Stephanie Bm, Alonso-Gonzalez Rafael, O'Brien Ciara M
Toronto ACHD Program, Division of Cardiology, University of Toronto, Toronto, Ontario, Canada.
Prince of Wales Hospital, Randwick, New South Wales, Australia.
JACC Adv. 2024 Oct 23;3(11):101357. doi: 10.1016/j.jacadv.2024.101357. eCollection 2024 Nov.
Fontan patients frequently develop liver cirrhosis (LC); however, the diagnostic accuracy of ultrasound (US) for detecting LC and the clinical implications of such diagnoses have not been clearly established.
This study aims to evaluate the diagnostic performance of US for detecting LC in an adult population with Fontan circulation and to determine the correlation between LC and mortality/transplantation.
This was a retrospective study. Data on cross-sectional imaging, liver USs, and clinical visits that occurred within 12 months of the cross-sectional imaging were collected. Liver US diagnostic accuracy was evaluated against cross-sectional imaging. Kappa agreement between methods was assessed. Univariate Cox proportional hazards regression analysis was employed to compare mortality and transplant outcomes.
Overall, 131 patients were included. Liver US and cross-sectional imaging (computed tomography 74, magnetic resonance imaging 57) was performed in all patients. Liver US reported heterogeneous parenchyma, lobar redistribution, and surface nodularity in 85.4%, 72.5%, and 65.6% of cases. Cross-sectional imaging reported these features in 60.3%, 87.0%, and 84.9% of cases, respectively. US sensitivity was greater than 0.75 for all variables, while specificity was 0.21, 0.58, and 0.85, respectively. LC was diagnosed in 78% of cases by US and in 90% by cross-sectional imaging, with a kappa agreement of 0.21 between techniques. There was no significant correlation between the presence of hepatic parenchymal changes or cirrhosis and mortality/transplantation.
Liver US is effective for screening and monitoring liver cirrhotic features in the adult Fontan population. In a univariate analysis, there was no association between LC and mortality or transplantation.
Fontan手术患者常发生肝硬化(LC);然而,超声(US)检测LC的诊断准确性以及此类诊断的临床意义尚未明确确立。
本研究旨在评估US在Fontan循环成年人群中检测LC的诊断性能,并确定LC与死亡率/移植之间的相关性。
这是一项回顾性研究。收集了横断面成像、肝脏超声以及在横断面成像后12个月内进行的临床就诊数据。根据横断面成像评估肝脏超声诊断准确性。评估两种方法之间的kappa一致性。采用单变量Cox比例风险回归分析比较死亡率和移植结局。
共纳入131例患者。所有患者均进行了肝脏超声和横断面成像(计算机断层扫描74例,磁共振成像57例)。肝脏超声报告85.4%、72.5%和65.6%的病例存在实质不均匀、叶内血流重新分布和表面结节。横断面成像分别报告这些特征的病例比例为60.3%、87.0%和84.9%。US对所有变量的敏感性均大于0.75,而特异性分别为0.21、0.58和0.85。US诊断LC的病例占78%,横断面成像诊断的病例占90%,两种技术之间的kappa一致性为0.21。肝实质改变或肝硬化的存在与死亡率/移植之间无显著相关性。
肝脏超声对Fontan成年人群肝硬化特征的筛查和监测有效。单变量分析显示,LC与死亡率或移植之间无关联。